- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05006027
Feasibility of PCI Using a 7-Fr Thin-Walled Sheath Via the DRA (SEVEN-BOX)
November 20, 2025 updated by: Yongcheol Kim, Yonsei University
Feasibility of Percutaneous Coronary Intervention Using a 7-Fr Thin Walled Sheath Via the Distal Radial Approach: a Prospective Observational Study (SEVEN-BOX)
To evaluate the safety and effectiveness of percutaneous coronary intervention using a 7-French(Fr) thin-walled sheath via the distal radial approach
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Recently, coronary angiography (CAG) and percutaneous coronary intervention (PCI) via the distal radial artery access (DRA) have shown several advantages owing to fewer complications, such as radial artery occlusion, pseudoaneurysms, and arteriovenous(AV) fistulas, and short hemostasis duration than the proximal radial access (PRA).
However, despite the potential advantages of the DRA, there are still many cardiologists who prefer the femoral approach for complex PCI including left main disease, bifurcation lesions, heavily calcified lesions, which need a strong backup and using several devices.
The radial artery and the distal radial artery have a smaller diameter than the femoral artery, and interventional cardiologists are usually performed using the 6-Fr sheath.
The previously developed 7-Fr sheath has a higher risk of vascular occlusion when use in a radial artery due to larger diameter compared to radial artery in 30% to 60% of patients.
However, with the recent development of various technologies, the outer diameter of the sheath is gradually becoming thinner and recently a 7-Fr thin-walled sheath which does not differ significantly from the outer diameter of the 6-Fr sheath used in the previously PRA demonstrated that feasibility and safety for radial artery intervention.
Despite the feasibility and potential benefits of the DRA and 7-Fr thin-walled sheath for radial artery, there is a lack of data regarding the safety and efficacy of a 7-Fr thin-walled sheath during the DRA.
Study Type
Observational
Enrollment (Actual)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Yŏngin, South Korea
- Yongin Severance Hospital
-
-
Gyeonggi-do
-
Yongin, Gyeonggi-do, South Korea, 16995
- Yongin Severance Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
patients with coronary artery disease who planned to perform PCI using a 7-Fr thin-walled sheath will be recruited
Description
Inclusion Criteria:
- Patients, ≥ 19 years of age, who were diagnosed with ischemic heart disease requiring percutaneous coronary intervention (PCI)
- Patients who are palpable distal radial artery
- The decision to participate voluntarily in this study and the written consent of the patient
- Patients who planned to perform PCI using a 7-Fr thin-walled sheath
Exclusion Criteria:
- Patients who are not palpable distal radial artery
- Female of childbearing potential, who possibly plans to become pregnant any time after enrollment into this study
- Pregnancy
- Patients who are not appropriate for this study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Percutaneous coronary intervention using a 7-Fr thin-walled sheath via the distal radial approach
patients with coronary artery disease who planned to perform PCI using 7-Fr thin-walled sheath via the distal radial approach
|
Percutaneous coronary intervention using a 7-Fr thin walled sheath (Prelude IDeal, MERIT MEDICAL, South Jordan, UT, USA) via the distal radial approach
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Access site complication during hospitalization and within 1-month follow-up
Time Frame: Through procedure completion, up to 1month
|
bleeding(defined by BARC criteria), hematoma (using modified EASY[Early Discharge After Transradial Stenting of Coronary Arteries Study] classification: A) Grade Ia hematoma was subclassified into 4 grades from the puncture site [Grade 1, <2cm; Grade2, 2-5cm; Grade3,>5cm; and grade 4, hand swelling], B) Grade Ib, wrist < 5cm, C) Grade II, wrist < 10cm, D) Grade III, forearm, E) Grade IV, upper arm), numbness, AV fistula, Pseudoaneurysm, and conventional and distal radial artery occlusion (assessed by manual palpation or ultrasonography[prefer])
|
Through procedure completion, up to 1month
|
|
Success rate of PCI
Time Frame: Through procedure completion, up to 1month
|
Success rate of PCI using 7-Fr sheath via the distal radial approach (%)
|
Through procedure completion, up to 1month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hemostasis duration
Time Frame: Through procedure completion, up to 24 hours
|
Hemostasis duration using 7-Fr thin-walled sheath via the distal radial approach (minute)
|
Through procedure completion, up to 24 hours
|
|
Patency of proximal radial artery after hemostasis
Time Frame: Through procedure completion, up to 24 hours
|
Patency of proximal radial artery using 7-Fr thin-walled sheath via the distal radial approach by ultrasonography after hemostasis (%)
|
Through procedure completion, up to 24 hours
|
|
Patency of distal radial artery after 1 month
Time Frame: Time Frame: up to 1month
|
Patency of distal radial artery using 7-Fr thin-walled sheath via the snuffbox approach by ultrasonography after 1-month (%)
|
Time Frame: up to 1month
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
If intravascular imaging modalities (OCT/IVUS) are seen during intervention, check for conventional radial radial artery complications through OCT/IVUS
Time Frame: Through procedure completion
|
If intravascular imaging modalities (OCT/IVUS) are seen during intervention, check for conventional radial radial artery complications through OCT/IVUS
|
Through procedure completion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Yongcheol Kim, MD, Yongin Severance Hopistal
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 16, 2021
Primary Completion (Actual)
July 17, 2024
Study Completion (Actual)
October 15, 2024
Study Registration Dates
First Submitted
August 8, 2021
First Submitted That Met QC Criteria
August 12, 2021
First Posted (Actual)
August 16, 2021
Study Record Updates
Last Update Posted (Estimated)
November 25, 2025
Last Update Submitted That Met QC Criteria
November 20, 2025
Last Verified
November 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 9-2021-0031
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
No planned
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Infirmerie Protestante de LyonRecruitingCoronary Artery Bypass | Coronary Artery Disease(CAD) | Off Pump Coronary Artery Bypass Surgery | Hemodynamic Optimization | Hemodynamic Management | Off Pump Coronary Artery Bypass Graft | Coronary Artery Disease With Need for Bypass Surgery | NoradrenalineFrance
-
Shanghai Bluesail Boyuan Medical Technology Co....Not yet recruitingCoronary Artery Disease | Coronary Artery Calcification | Severe Coronary Artery DiseaseChina
-
Scitech Produtos Medicos SANot yet recruitingCoronary Artery Disease (CAD) | Multivessel Coronary Artery Disease | Complex Coronary Lesions | Calcific Coronary Arteriosclerosis | Small Vessel Ischemic Disease | Stenosis CoronaryBrazil
-
Istanbul Mehmet Akif Ersoy Educational and Training...Bakirkoy Dr. Sadi Konuk Research and Training Hospital; Ege University; Istanbul... and other collaboratorsActive, not recruitingCoronary Artery Disease (CAD) | Coronary Bifurcation Lesion | Left Main Coronary Artery StenosisTurkey (Türkiye)
-
I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioCompletedCoronary Artery Disease (CAD) | Atherosclerosis of Coronary ArteryItaly
-
EBI Anti Sepsis BVCR2O B.V.Not yet recruitingCoronary Artery Disease (CAD) | Coronary Artery Bypass Graft Surgery(CABG)United States, Netherlands, Belgium, United Kingdom
-
University Medical Centre LjubljanaRecruitingCoronary Artery Disease With Myocardial InfarctionSlovenia
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Shunmei MedicalNot yet recruitingCalcified Coronary Artery Disease | Coronary Arterial DiseasePoland, France, Spain
-
OPCI Core Laboratories LLCNot yet recruitingCoronary Artery Disease (CAD) | Coronary Calcification | Coronary Calcified Disease | Coronary Calcified NodulesUnited States
Clinical Trials on Percutaneous coronary intervention via the distal radial approach
-
Hospital Arnau de VilanovaHospital Universitari de Bellvitge; Hospital Universitari Joan XXIII de Tarragona... and other collaboratorsRecruitingCoronary Artery Disease | Angina, Stable | Angina, Unstable | STEMI | Hematoma | Procedural Pain | Vascular Access Complication | Non STEMI | Artery Occlusion | Procedural Blood Vessel PunctureSpain
-
Cai gaojun, MDRecruitingCoronary Artery DiseaseChina
-
Albert Schweitzer HospitalUnknownUpper Extremity DysfunctionNetherlands
-
Chonnam National University HospitalThe Catholic University of Korea; Wakayama Medical UniversityCompletedBleeding | Artery InjuryKorea, Republic of
-
Minneapolis Heart Institute FoundationActive, not recruitingPercutaneous Coronary Intervention | Target Vessel Failure in Saphenous Vein GraftsUnited States
-
Instituto Nacional de Cardiologia Ignacio ChavezRecruitingMyocardial Infarction | Acute Coronary Syndrome | STEMI - ST Elevation Myocardial InfarctionMexico
-
Shanghai MicroPort Rhythm MedTech Co., Ltd.Not yet recruiting
-
Irmandade Santa Casa Misericórdia MaríliaCompleted
-
Azienda Ospedaliera Città della Salute e della...RecruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Left Main Coronary Artery Disease | Coronary Stenosis | Stent RestenosisItaly
-
Imperial College LondonRoyal Free Hospital NHS Foundation Trust; Mid and South Essex NHS Foundation... and other collaboratorsRecruitingCoronary Artery Disease(CAD) | Ischaemic Heart Desease | Angina (Stable)United Kingdom